Pay in 4 interest-free payments of $6.08 Learn more
Ships within 48 hours · Estimated delivery Nov 8 - Nov 13
Preclinical studies have shown it may protect the gastric mucosa from damage caused by NSAIDs, alcohol, and other mucosal irritants
IV drips can include antioxidants and other detoxifying ingredients that support the liver and help flush out these harmful substances more efficiently
Competing interests The authors declare that they have no competing interests
TB-500, a synthetic fragment of Thymosin Beta-4, regulates actin polymerization and F-actin formation
Neither were published and Pliva was so excited about the results it abandoned the drug entirely One Phase I safety and pharmacokinetics trial of oral BPC-157, registered in 2015, that has no public results and appears to have been withdrawn or abandoned Three small and nonrandomized uncontrolled pilot studies from a single for-profit clinic in Florida, which included a 16-patient knee-pain chart review, a 12-woman interstitial cystitis study, and a small intravenous safety study One legitimate entry: a registered Phase 2 trial of BPC-157 for acute hamstring strain
